Large cell neuroendocrine carcinoma of the lung controlled for 4 years by a single administration of pembrolizumab: A case report

Large cell neuroendocrine carcinoma of the lung (LCNEC) is a rare and highly progressive tumor with a poor prognosis. Although immune checkpoint inhibitors have been approved for treatment of both small cell and non–small cell lung cancers, their role in the treatment of LCNEC is unclear. We describ...

Descripción completa

Detalles Bibliográficos
Autores principales: Watanabe, Masayuki, Matsumura, Yuki, Yamaguchi, Hikaru, Mine, Hayato, Takagi, Hironori, Ozaki, Yuki, Fukuhara, Mitsuro, Muto, Satoshi, Okabe, Naoyuki, Shio, Yutaka, Suzuki, Hiroyuki
Formato: Online Artículo Texto
Lenguaje:English
Publicado: John Wiley & Sons Australia, Ltd 2022
Materias:
Case Reports
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9527153/
https://www.ncbi.nlm.nih.gov/pubmed/36064196
http://dx.doi.org/10.1111/1759-7714.14615

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9527153/
https://www.ncbi.nlm.nih.gov/pubmed/36064196
http://dx.doi.org/10.1111/1759-7714.14615

Ejemplares similares